Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by stockmonster6on Jan 13, 2022 11:59am
109 Views
Post# 34313014

Volume and Price says

Volume and Price saysNo news coming this week.
Maybe next, or next, or next, or next.
Pandemic may be over before this ever gets approved.

less than a year for approval for invasive vaccines.  
more than a year for a spit test.  something is seriously wrong here.
and the stock price shows it.

Don't bank on Morningstar valuations, that is not a way to determine future value.
I am starting to lose hope that THRM is going to get to the finish line.  
My income trust since last year is up $3.50 and my funds may have been better spent there, with 10% dividend rather than with THRM.

Given the amount of time, and total lack of communication - I have a feeling the results were NOT as expected and they are massively back peddling to avoid potential class actions suits for lying to the share holders about the test results in Brazil.
<< Previous
Bullboard Posts
Next >>